Home2HA • FRA
add
Spero Therapeutics Inc
Previous close
€1.87
Day range
€1.81 - €1.81
Year range
€0.45 - €2.66
Market cap
129.02M USD
Avg Volume
28.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.44M | -59.60% |
Operating expense | 4.17M | -19.70% |
Net income | -7.38M | 56.95% |
Net profit margin | -135.65 | -6.55% |
Earnings per share | — | — |
EBITDA | -7.33M | 60.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.62M | -36.27% |
Total assets | 54.17M | -59.92% |
Total liabilities | 27.68M | -60.27% |
Total equity | 26.49M | — |
Shares outstanding | 56.34M | — |
Price to book | 3.98 | — |
Return on assets | -31.51% | — |
Return on capital | -55.28% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.38M | 56.95% |
Cash from operations | 17.42M | 36.50% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 17.42M | 36.50% |
Free cash flow | 19.62M | 838.43% |
About
Founded
2013
Website
Employees
32
